MeadowBrook Investment Advisors LLC Trims Stake in Waters Co. (NYSE:WAT)

MeadowBrook Investment Advisors LLC lowered its holdings in Waters Co. (NYSE:WAT) by 4.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,355 shares of the medical instruments supplier’s stock after selling 59 shares during the period. MeadowBrook Investment Advisors LLC’s holdings in Waters were worth $503,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kennebec Savings Bank purchased a new stake in shares of Waters in the 3rd quarter valued at $33,000. Fortitude Family Office LLC increased its holdings in Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Waters during the 3rd quarter worth about $35,000. R Squared Ltd purchased a new stake in Waters during the 4th quarter worth about $63,000. Finally, Itau Unibanco Holding S.A. boosted its position in shares of Waters by 63.2% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after acquiring an additional 72 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

WAT has been the subject of several analyst reports. Barclays raised Waters from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $360.00 to $415.00 in a research report on Monday. Wells Fargo & Company increased their price objective on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft increased their price objective on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Stifel Nicolaus raised their price objective on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Scotiabank assumed coverage on shares of Waters in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $430.00 price objective for the company. Ten research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $388.64.

Waters Trading Down 0.6 %

NYSE WAT opened at $405.28 on Wednesday. The stock has a market cap of $24.07 billion, a P/E ratio of 38.67, a PEG ratio of 7.37 and a beta of 1.01. The company’s fifty day simple moving average is $390.34 and its 200-day simple moving average is $363.72. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.